WEBINAR – Difficult-to-treat and severe asthma: changing the paradigm

A significant group of people with asthma still have uncontrolled asthma and experience poor outcomes despite high-dose standard therapy. However, recent advances offer hope for improving these outcomes. This webinar by NPS MedicineWise presents a multidisciplinary discussion on new therapies, and how to identify and manage difficult-to-treat and severe asthma. CPD accreditation is available by viewing this webinar on the NPS MedicineWise e-learning site https://learn.nps.org.au/course/view.... To download presentation slides, visit https://www.nps.org.au/webinar/asthma ---------------------- This program is joint-funded by AstraZeneca Pty Ltd and Novartis Pharmaceuticals Australia Pty Ltd and managed by VentureWise, a wholly owned commercial subsidiary of NPS MedicineWise. The content has been designed, developed and delivered by NPS MedicineWise with complete independence and editorial control, based on best practice guidelines.